HHS orders removal of mercury-based preservative from flu vaccines, despite scientific consensus on its safety.
Lamb Weston announces strategic restructuring, targeting $250 million in cost savings by 2028, driven by robust international sales and disciplined cost management.
HHS orders removal of mercury-based preservative from flu vaccines, despite scientific consensus on its safety.
Lamb Weston announces strategic restructuring, targeting $250 million in cost savings by 2028, driven by robust international sales and disciplined cost management.